Conference abstract · 25 Sep 2017
Conference abstractPublished 25 Sep 2017
Data integrity requirements for GxPs
QACV Consulting LLC, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This presentation will provide an overview of current regulatory requirements and guidance pertaining to data integrity. The presentation will review FDA, MHRA and other regulatory guidance related to data integrity. Approaches to performing data integrity assessments will be discussed and examples from audits and regulatory observations will be reviewed. Implementation of data integrity programs will also be reviewed. The following topics will be discussed at the conference: Review current regulatory data integrity requirements and guidance; approaches to conduct audits / assessments of data integrity programs; examples of data integrity observations and audit findings and; implementing data integrity programs.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 30 Mar 2026
Data Auditing Methodologies: Ensuring Accuracy, Integrity, and Accountability
Article · 30 Sep 2025
Data Integrity and Ethical Practice in Analytical Reporting
Perspective · 30 May 2025
Integrating Clinical Trial Data Using Model-Based Meta-Analysis: A New Standard for Dose Optimization
Short communication · 25 Sep 2024
Toxicogenomics: Integrating Genomic Data to Predict and Reduce Drug-Induced Toxicities
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chris Wubbolt”

